FILE PHOTO: A injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo
Mounjaro, which uses the same active ingredient, was approved for diabetes patients last year, but some consumers were using it off-label for weight loss.Conagra might consider changing portion sizes of its snacks if the rising use of weight-loss drugs leads to a change in food consumption patterns. Hershey's CEO Michele Buck said the use of the drugs was not materially impacting the chocolate maker's business.
Abbott Laboratories, which makes glucose monitoring products, has said that the market was overestimating the impact to its sales from growing popularity of the drugs.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: